M Erkan

Summary

Affiliation: Klinikum rechts der Isar
Country: Germany

Publications

  1. ncbi Tumor microenvironment and progression of pancreatic cancer
    M Erkan
    Department of Surgery, Technische Universitat Munchen, Ismaningerstrasse 22, Munich 81675, Germany
    Exp Oncol 32:128-31. 2010
  2. pmc Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells
    Mert Erkan
    Department of General Surgery, Technische Universitat Munchen, Munich, Germany
    Mol Cancer 9:88. 2010
  3. doi AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling
    B Kong
    Department of Surgery, Technische Universitat Munchen, Munich, Germany
    Oncogene 29:5146-58. 2010
  4. ncbi Strategies to improve the outcome in locally advanced pancreatic cancer
    C Spath
    Department of Surgery, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Minerva Chir 70:97-106. 2015
  5. pmc Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer
    C W Michalski
    Department of General Surgery, Technische Universitat Munchen, Munich, Germany
    Br J Cancer 99:760-7. 2008
  6. doi Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours
    K Herrmann
    Department of Nuclear Medicine, Technische Universitat Munchen, Ismaningerstr 22, 81675 Munich, Germany
    Eur J Nucl Med Mol Imaging 39:846-51. 2012

Collaborators

Detail Information

Publications6

  1. ncbi Tumor microenvironment and progression of pancreatic cancer
    M Erkan
    Department of Surgery, Technische Universitat Munchen, Ismaningerstrasse 22, Munich 81675, Germany
    Exp Oncol 32:128-31. 2010
    ..The common denominator of all these conditions is; chronic inflammation leads to increased incidence of cancer. In this review the impact of the activated stroma on pancreatic carcinogenesis is discussed...
  2. pmc Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells
    Mert Erkan
    Department of General Surgery, Technische Universitat Munchen, Munich, Germany
    Mol Cancer 9:88. 2010
    ..To identify organ- and disease-specific stellate cell transcriptional fingerprints, we employed genome-wide transcriptional analysis of primary human PSC and HSC isolated from patients with chronic inflammation or cancer...
  3. doi AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling
    B Kong
    Department of Surgery, Technische Universitat Munchen, Munich, Germany
    Oncogene 29:5146-58. 2010
    ..Thus, epigenetically regulated ZAG is a novel tumor suppressor essential for maintaining an epithelial phenotype...
  4. ncbi Strategies to improve the outcome in locally advanced pancreatic cancer
    C Spath
    Department of Surgery, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Minerva Chir 70:97-106. 2015
    ..This article gives an overview on current therapy standards as well as on new approaches especially for locally advanced tumors and outlines the importance of ongoing research to improve prognosis. ..
  5. pmc Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer
    C W Michalski
    Department of General Surgery, Technische Universitat Munchen, Munich, Germany
    Br J Cancer 99:760-7. 2008
    ..This suggests that ATP-TCA testing could be used as a decision-making tool in the adjuvant treatment of pancreatic cancer...
  6. doi Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours
    K Herrmann
    Department of Nuclear Medicine, Technische Universitat Munchen, Ismaningerstr 22, 81675 Munich, Germany
    Eur J Nucl Med Mol Imaging 39:846-51. 2012
    ....